Pfizer to Use Sofia Knowledgescan | GenomeWeb
NEW YORK (GenomeWeb News) - Pfizer has signed an agreement to use BioWisdom's Sofia KnowledgeScan, BioWisdom said today.
 
BioWisdom will also provide industry-trained healthcare analysts to perform research and examine the analyzed data.
 
Sofia KnowledgeScan is based on BioWisdom's Sofia Intelligence Platform and provides systematic analysis of data to support healthcare-related decision-making.
 
Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.